sur ARCHOS (EPA:ALJXR)
Dextrain HomeRehab: New Era in Manual Dexterity Rehabilitation
On April 16, 2024 in Paris, Dextrain, a subsidiary of the Medtech division of the ARCHOS group, announced the launch of HomeRehab, its new device for the rehabilitation of manual dexterity at home. Designed to help people suffering from motor deficits following a stroke, this equipment uses innovative force sensors allowing precise training of each finger.
The HomeRehab is characterized by its ergonomics and ease of use, offering patients the possibility of training independently at home. The device allows real-time monitoring of progress thanks to the integration of biofeedback and adapted therapeutic games. It is also equipped with artificial intelligence to personalize training sessions according to the patient's progress and goals.
The device received the Rééduca Innov' prize in 2023, demonstrating the acceptance and interest of health professionals in this technology. HomeRehab will be available to clinical partners and select patients in the coming weeks.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de ARCHOS